-
Getting ready to hand out some well deserved awards
#GGB18#GenericsBulletin#generics#biosimilarspic.twitter.com/B69oQ6mhjn
-
Click to subscribe or read the latest issue of the
#GenericsBulletin. http://bit.ly/2A0XWRM pic.twitter.com/mp7iD0ekiB
-
Slides in North America and Japan were primarily responsible for Lupin’s overall turnover suffering a slight decline in its financial first quarter ended 30 June 2018, according to the Indian firm. http://bit.ly/2CjiCr2 Subscribe to
#GenericsBulletin today! pic.twitter.com/mpNsQmVzvo
-
#Teva Pharmaceuticals receives#FDA EpiPen approval.. Read the Full Story when you sign up to a free 6 week trial: http://bit.ly/2wJJBWY#GenericsBulletin pic.twitter.com/5w83NcesRd
-
Grab your copy of the
#GenericsBulletin today and keep on top of the global news for the generic &#biosimilar medicines industries. http://bit.ly/2QD1Ky2 pic.twitter.com/7c6vVDcE0E
-
Boost your own strategy with key insights from other industry leaders with
#GenericsBulletin. Download your free article pack here http://bit.ly/31WZgjG pic.twitter.com/scd1udGKea
-
Have you started working on your
#GGBAwards14 entry yet? Download an Entry info pack from the#Genericsbulletin website.#GenericMedicines -
Beat the Monday Blues! Get 20% off
#Genericsbulletin online - Email subs@Generics-bulletin.com with#bluemonday as the subject to subscribe -
#GenericsBulletin provides updated coverage of market-moving events & strategy that can help you improve your own strategic, operational & tactical planning & execution. Download our free article pack to find out more http://bit.ly/2KOmmmY pic.twitter.com/UZe2yoqlLP
-
Entries now open for
@GGB_Awards. Download an Entry info pack from the#Genericsbulletin website.#GenericMedicines#GGBAwards14 -
Still 24 hours left to enter
@GGB_Awards. Download an entry pack from the#Genericsbulletin website.#GenericMedicines#GGBAwards14 -
#GenericsBulletin is your key to critical insights. Get articles such as:
#Gottlieb calls on congress to act on US#biosimilars uptake
US Employers could cut costs by encourage #biosimilar usage Download your free article pack here http://bit.ly/2oWyNVB pic.twitter.com/60dkfclHXm
-
AWARD @GGB_AWARD: Hovione, the API Supplier of the Year http://bit.ly/2e05oUw
#genericsbulletin#offpatentapiproducts#initforlifepic.twitter.com/W35vr6FngX
-
Inform your strategy & prepare for challenges, minimize risks & maximize opportunities with
#GenericsBulletin. Discover more about the forces at play in#generics with our free article pack. Download yours here: http://bit.ly/2KMHI3Z pic.twitter.com/9kjJRQFDlA
-
A huge 'Thank You' to all our Customers too!
#initforlife#offpatentapi#generics#genericsbulletin https://twitter.com/GGB_Awards/status/790866282010804224 …
-
Did you know that
#genericsbulletin provides indepth news & analysis on issues that matter most in the US#biosimilars market? Find out more in our free#articlepack here http://bit.ly/2JZkpTA pic.twitter.com/Gi1Q6QqDzY
-
Access essential US
#Biosimilars market information and insights with comprehensive coverage from#genericsbulletin. Get your free#articlepack here to see more http://bit.ly/34ByU81 pic.twitter.com/Dbd6pNPjsH
-
Nuestros clientes en la revista
#GenericsBulletin#Publicidad#Creatividad#Branding#Medios http://bit.ly/1P7j22U#TheBrandActivist
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.